A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

Table 5 Comparison of the NLR and PLR between the two patient groups

		Combined group	Monotherapy group	Difference	95%CI	P
NLR	Before	3.4	3.6	0.55	-1.79	0.2
NLR	Before	(2.1, 5.0)	(2.7, 5.8)	0.55	-1.79	0.2
	After	3.4	3.2	-0.59	-2.12	0.15
	After	(2.4, 5.4)	(2.4, 4.6)	-0.59	-2.12	0.15
PLR	Before	166.1	159.3	-14.63	-61.79	0.31
PLR	Before	(137.3, 258.7)	(132.2, 265.8)	-14.63	-61.79	0.31
	After	153	180	-7.02	-70.27	0.7
	After	(114.0, 243.0)	(111.7, 249.1)	-7.02	-70.27	0.7

ISSN: 2662-7671